A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9004 (Patidistrogene Bexoparvovec) in Participants With Limb-Girdle Muscular Dystrophy, Type 2D (LGMD2D)

NCT01976091 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Limb-Girdle Muscular Dystrophy, Type 2D

Interventions

GENETIC: SRP-9004

Sponsor

Sarepta Therapeutics, Inc.

Collaborators

[object Object]